Guardant Health Inc (GH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | GH | ROIV | ASND | ||
| Company | Guardant Health Inc | Roivant Sciences Ltd | Ascendis Pharma ADR | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 102.28 | 22.31 | 213.85 | ||
| High | 104.75 | 22.41 | 213.85 | ||
| Low | 101.50 | 22.08 | 208.14 | ||
| Latest | 102.98 | 22.23 | 208.98 | ||
| Change | +0.60 | -0.27 | -3.83 | ||
| % Change | +0.59% | -1.20% | -1.80% | ||
| Volume | 1,042,400 | 4,319,100 | 267,800 | ||
| 20-Day Average Volume | 1,870,735 | 8,247,825 | 761,115 | ||
| Previous Close | 102.38 | 22.50 | 212.81 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 102.68 | 21.53 | 207.19 | ||
| 20-Day Raw Stochastic | 50.33% | 64.67% | 44.34% | ||
| 20-Day Relative Strength | 58.85 | 60.78 | 51.59 | ||
| Weighted Alpha | +176.67 | +119.44 | +50.18 | ||
| Today's Opinion | 96% Buy | 100% Buy | 96% Buy | ||
| Previous Opinion | 80% Buy | 100% Buy | 96% Buy | ||
| Last Month's Opinion | 100% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.06% since 12/18/25 | +2.02% since 12/18/25 | +4.59% since 12/18/25 | ||
| Low | 96.51 on 12/19/25 | 21.73 on 12/19/25 | 197.15 on 12/19/25 | ||
| High | 104.75 on 12/26/25 | 22.76 on 12/22/25 | 216.19 on 12/24/25 | ||
| 1-Month | |||||
| %Chg | -4.46% since 11/26/25 | +6.52% since 11/26/25 | -0.49% since 11/26/25 | ||
| Low | 96.28 on 12/18/25 | 19.96 on 12/02/25 | 192.28 on 12/10/25 | ||
| High | 109.59 on 12/04/25 | 23.47 on 12/17/25 | 229.94 on 12/12/25 | ||
| 3-Month | |||||
| %Chg | +71.55% since 09/26/25 | +46.54% since 09/26/25 | +8.85% since 09/26/25 | ||
| Low | 59.63 on 09/29/25 | 14.86 on 09/29/25 | 186.05 on 10/20/25 | ||
| High | 112.43 on 11/25/25 | 23.47 on 12/17/25 | 229.94 on 12/12/25 | ||
| 6-Month | |||||
| %Chg | +105.84% since 06/26/25 | +91.64% since 06/26/25 | +20.83% since 06/26/25 | ||
| Low | 40.35 on 08/01/25 | 10.70 on 07/08/25 | 160.86 on 07/29/25 | ||
| High | 112.43 on 11/25/25 | 23.47 on 12/17/25 | 229.94 on 12/12/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 12,979,702 | 15,460,788 | 12,942,548 | ||
| Shares Outstanding, K | 126,041 | 695,492 | 61,932 | ||
| Annual Sales | 739,020,000 | 29,050,000 | 393,500,000 | ||
| Annual Net Income | -436,370,000 | -171,980,000 | -409,120,000 | ||
| Last Quarter Sales | 265,200,000 | 1,570,000 | 249,720,000 | ||
| Last Quarter Net Income | -92,730,000 | -113,520,000 | -71,290,000 | ||
| 60-Month Beta | 1.58 | 1.22 | 0.45 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.39 on 10/29/25 | -0.28 on 11/10/25 | -1.17 on 11/12/25 | ||
| Latest Earnings Date | 02/19/26 | 02/09/26 | 02/11/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||